Asia Pacific Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity
Asia Pacific pharmaceutical continuous manufacturing market will grow by 12.8% annually with a total addressable market cap of $5,299.8 million over 2020-2030 owing to the rising need for continuous manufacturing process due to cost saving and improved productivity.
Highlighted with 32 tables and 42 figures, this 113-page report “Asia Pacific Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 32 tables and 42 figures, this 113-page report “Asia Pacific Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
- Continuous Granulators
- Continuous Blenders
- Continuous Compressors
- Continuous Coaters
- Continuous Dryers
- Other Semi-Continuous Systems
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
- Solid Dosage Manufacturing
- Liquid Dosage Manufacturing
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- Research Organizations and Institutes
- Other End Users
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Integrated Continuous Systems
3.3 Semi-Continuous Systems
3.3.1 Continuous Granulators
3.3.2 Continuous Blenders
3.3.3 Continuous Compressors
3.3.4 Continuous Coaters
3.3.5 Continuous Dryers
3.3.6 Other Semi-Continuous Systems
3.4 Controls & Software
4 SEGMENTATION OF ASIA PACIFIC MARKET BY APPLICATION
4.1 Market Overview by Application
4.2 End Product Manufacturing
4.2.1 Solid Dosage Manufacturing
4.2.2 Liquid Dosage Manufacturing
4.3 API Manufacturing
5 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER
5.1 Market Overview by End User
5.2 Pharmaceutical Companies
5.3 Contract Manufacturing Organizations
5.4 Research Organizations and Institutes
5.5 Other End Users
6 ASIA-PACIFIC MARKET 2019-2030 BY COUNTRY
6.1 Overview of Asia-Pacific Market
6.2 Japan
6.3 China
6.4 Australia
6.5 India
6.6 South Korea
6.7 Rest of APAC Region
7 COMPETITIVE LANDSCAPE
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
8 INVESTING IN ASIA PACIFIC MARKET: RISK ASSESSMENT AND MANAGEMENT
8.1 Risk Evaluation of Asia Pacific Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Integrated Continuous Systems
3.3 Semi-Continuous Systems
3.3.1 Continuous Granulators
3.3.2 Continuous Blenders
3.3.3 Continuous Compressors
3.3.4 Continuous Coaters
3.3.5 Continuous Dryers
3.3.6 Other Semi-Continuous Systems
3.4 Controls & Software
4 SEGMENTATION OF ASIA PACIFIC MARKET BY APPLICATION
4.1 Market Overview by Application
4.2 End Product Manufacturing
4.2.1 Solid Dosage Manufacturing
4.2.2 Liquid Dosage Manufacturing
4.3 API Manufacturing
5 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER
5.1 Market Overview by End User
5.2 Pharmaceutical Companies
5.3 Contract Manufacturing Organizations
5.4 Research Organizations and Institutes
5.5 Other End Users
6 ASIA-PACIFIC MARKET 2019-2030 BY COUNTRY
6.1 Overview of Asia-Pacific Market
6.2 Japan
6.3 China
6.4 Australia
6.5 India
6.6 South Korea
6.7 Rest of APAC Region
7 COMPETITIVE LANDSCAPE
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
8 INVESTING IN ASIA PACIFIC MARKET: RISK ASSESSMENT AND MANAGEMENT
8.1 Risk Evaluation of Asia Pacific Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products
LIST OF TABLES
Table 1. Snapshot of Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical Continuous Manufacturing Market
Table 4. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn
Table 6. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 7. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn
Table 8. Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 9. APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn
Table 10. Japan Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 11. Japan Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 12. Japan Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 13. China Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 14. China Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 15. China Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 16. Australia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 17. Australia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 18. Australia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 19. India Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 20. India Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 21. India Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 22. South Korea Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 23. South Korea Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 24. South Korea Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 25. Pharmaceutical Continuous Manufacturing Market in Rest of APAC by Country, 2019-2030, $ mn
Table 26. ACG Group: Company Snapshot
Table 27. ACG Group: Business Segmentation
Table 28. ACG Group: Product Portfolio
Table 29. ACG Group: Revenue, 2016-2018, $ mn
Table 30. ACG Group: Recent Developments
Table 31. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030
Table 32. Critical Success Factors and Key Takeaways
Table 1. Snapshot of Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical Continuous Manufacturing Market
Table 4. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn
Table 6. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 7. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn
Table 8. Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 9. APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn
Table 10. Japan Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 11. Japan Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 12. Japan Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 13. China Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 14. China Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 15. China Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 16. Australia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 17. Australia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 18. Australia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 19. India Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 20. India Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 21. India Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 22. South Korea Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 23. South Korea Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 24. South Korea Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 25. Pharmaceutical Continuous Manufacturing Market in Rest of APAC by Country, 2019-2030, $ mn
Table 26. ACG Group: Company Snapshot
Table 27. ACG Group: Business Segmentation
Table 28. ACG Group: Product Portfolio
Table 29. ACG Group: Revenue, 2016-2018, $ mn
Table 30. ACG Group: Recent Developments
Table 31. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030
Table 32. Critical Success Factors and Key Takeaways
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical Continuous Manufacturing Market
Figure 11. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 13. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn
Figure 14. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn
Figure 15. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn
Figure 16. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn
Figure 17. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn
Figure 18. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn
Figure 19. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn
Figure 20. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn
Figure 21. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn
Figure 22. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue
Figure 23. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 24. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn
Figure 25. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn
Figure 26. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn
Figure 27. Asia Pacific Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn
Figure 28. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue
Figure 29. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 30. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn
Figure 31. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn
Figure 32. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn
Figure 33. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn
Figure 34. Breakdown of APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. Pharmaceutical Continuous Manufacturing Market in Japan, 2019-2030, $ mn
Figure 37. Pharmaceutical Continuous Manufacturing Market in China, 2019-2030, $ mn
Figure 38. Pharmaceutical Continuous Manufacturing Market in Australia, 2019-2030, $ mn
Figure 39. Pharmaceutical Continuous Manufacturing Market in India, 2019-2030, $ mn
Figure 40. Pharmaceutical Continuous Manufacturing Market in South Korea, 2019-2030, $ mn
Figure 41. Pharmaceutical Continuous Manufacturing Market in Rest of APAC, 2019-2030, $ mn
Figure 42. Growth Stage of Asia Pacific Pharmaceutical Continuous Manufacturing Industry over the Forecast Period
COMPANIES MENTIONED
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical Continuous Manufacturing Market
Figure 11. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 13. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn
Figure 14. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn
Figure 15. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn
Figure 16. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn
Figure 17. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn
Figure 18. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn
Figure 19. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn
Figure 20. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn
Figure 21. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn
Figure 22. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue
Figure 23. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 24. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn
Figure 25. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn
Figure 26. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn
Figure 27. Asia Pacific Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn
Figure 28. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue
Figure 29. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 30. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn
Figure 31. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn
Figure 32. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn
Figure 33. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn
Figure 34. Breakdown of APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. Pharmaceutical Continuous Manufacturing Market in Japan, 2019-2030, $ mn
Figure 37. Pharmaceutical Continuous Manufacturing Market in China, 2019-2030, $ mn
Figure 38. Pharmaceutical Continuous Manufacturing Market in Australia, 2019-2030, $ mn
Figure 39. Pharmaceutical Continuous Manufacturing Market in India, 2019-2030, $ mn
Figure 40. Pharmaceutical Continuous Manufacturing Market in South Korea, 2019-2030, $ mn
Figure 41. Pharmaceutical Continuous Manufacturing Market in Rest of APAC, 2019-2030, $ mn
Figure 42. Growth Stage of Asia Pacific Pharmaceutical Continuous Manufacturing Industry over the Forecast Period
COMPANIES MENTIONED
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
